Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3658)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
821
Price
$539.63
Total Value
$443.03K
Shares Held After
325,879
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
423
Price
$538.70
Total Value
$227.87K
Shares Held After
326,700
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$537.45
Total Value
$623.44K
Shares Held After
327,123
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,110
Price
$536.36
Total Value
$1.13M
Shares Held After
328,283
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,350
Price
$535.53
Total Value
$1.26M
Shares Held After
330,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$534.57
Total Value
$384.89K
Shares Held After
332,743
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.83
Total Value
$127.40K
Shares Held After
333,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$528.91
Total Value
$126.94K
Shares Held After
333,703
% of Holdings
0.1%
Lyell Immunopharma, Inc. (LYEL)
Innovative Cellular Therapeutics Holdings Ltd — 10% Owner
Shares
10
Price
$13.70
Total Value
$137.00
Shares Held After
2,857,480
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
200
Price
$38.39
Total Value
$7.68K
Shares Held After
174,906
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
14,140
Price
$37.70
Total Value
$533.08K
Shares Held After
175,106
% of Holdings
7.5%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
2,833
Price
$37.05
Total Value
$104.96K
Shares Held After
189,246
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
900
Price
$38.17
Total Value
$34.35K
Shares Held After
144,240
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
16,969
Price
$37.61
Total Value
$638.20K
Shares Held After
145,140
% of Holdings
10.5%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
600
Price
$36.51
Total Value
$21.91K
Shares Held After
162,109
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
16,779
Price
$37.90
Total Value
$635.92K
Shares Held After
1,246,455
% of Holdings
1.3%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
52,485
Price
$4.06
Total Value
$213.09K
Shares Held After
824,918
% of Holdings
6.0%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
2,077
Price
$37.90
Total Value
$78.72K
Shares Held After
224,462
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
3,656
Price
$37.90
Total Value
$138.56K
Shares Held After
298,901
% of Holdings
1.2%
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel&Secretary
Shares
24,109
Price
$4.05
Total Value
$97.64K
Shares Held After
797,554
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
1,130
Price
$37.90
Total Value
$42.83K
Shares Held After
145,823
% of Holdings
0.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
51
Price
$315.06
Total Value
$16.07K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
740
Price
$314.32
Total Value
$232.60K
Shares Held After
51
% of Holdings
93.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,915
Price
$313.19
Total Value
$4.67M
Shares Held After
791
% of Holdings
95.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
35,829
Price
$312.17
Total Value
$11.18M
Shares Held After
15,706
% of Holdings
69.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,543
Price
$311.42
Total Value
$1.73M
Shares Held After
51,535
% of Holdings
9.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4,833
Price
$310.37
Total Value
$1.50M
Shares Held After
57,078
% of Holdings
7.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
680
Price
$309.05
Total Value
$210.16K
Shares Held After
61,911
% of Holdings
1.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
597
Price
$306.96
Total Value
$183.26K
Shares Held After
62,591
% of Holdings
0.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,440
Price
$305.20
Total Value
$439.49K
Shares Held After
63,188
% of Holdings
2.2%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
213
Price
$19.75
Total Value
$4.21K
Shares Held After
4,501,882
% of Holdings
0.0%
ImageneBio, Inc. (IMA)
Lally Robert B — Principal Accounting Officer
Shares
1,671
Price
$5.50
Total Value
$9.19K
Shares Held After
57,107
% of Holdings
2.8%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
116,671
Price
$3.56
Total Value
$415.35K
Shares Held After
7,030,000
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$23.00
Total Value
$115.00K
Shares Held After
401,288
% of Holdings
1.2%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
152,472
Price
$8.93
Total Value
$1.36M
Shares Held After
16,970,045
% of Holdings
0.9%
CRESCENT BIOPHARMA, INC. (CBIO)
Fairmount Funds Management LLC — Director
Shares
853,450
Price
$14.50
Total Value
$12.38M
Shares Held After
3,601,316
% of Holdings
23.7%
INCYTE CORP (INCY)
Issa Mohamed Khairie — EVP, Head of U.S. Commercial
Shares
1,093
Price
$115.01
Total Value
$125.71K
Shares Held After
63,940
% of Holdings
1.7%
INCYTE CORP (INCY)
Stein Steven H — CMO&Head of Late-Stage Dev.
Shares
1,877
Price
$114.73
Total Value
$215.35K
Shares Held After
21,118
% of Holdings
8.2%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
1,592
Price
$37.44
Total Value
$59.60K
Shares Held After
192,079
% of Holdings
0.8%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
7,464
Price
$36.66
Total Value
$273.63K
Shares Held After
193,671
% of Holdings
3.7%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
1,476
Price
$37.44
Total Value
$55.26K
Shares Held After
162,709
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
6,979
Price
$36.66
Total Value
$255.85K
Shares Held After
164,185
% of Holdings
4.1%
Lyell Immunopharma, Inc. (LYEL)
Innovative Cellular Therapeutics Holdings Ltd — 10% Owner
Shares
10
Price
$13.73
Total Value
$137.30
Shares Held After
2,857,490
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
92
Price
$37.96
Total Value
$3.49K
Shares Held After
1,263,234
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
28,091
Price
$37.26
Total Value
$1.05M
Shares Held After
1,263,326
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
40,899
Price
$36.46
Total Value
$1.49M
Shares Held After
1,291,417
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
12
Price
$37.96
Total Value
$455.52
Shares Held After
226,539
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
3,526
Price
$37.26
Total Value
$131.38K
Shares Held After
226,551
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,009
Price
$36.45
Total Value
$182.58K
Shares Held After
230,077
% of Holdings
2.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
19
Price
$37.96
Total Value
$721.24
Shares Held After
302,557
% of Holdings
0.0%
Showing 51–100 of 3658 transactions (page 2 of 74)